Skip to main content

Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience.

Publication ,  Conference
Friedman, DR; Patil, V; Rasmussen, KM; Sauer, BC; Kelley, MJ; Halwani, AS
Published in: Journal of Clinical Oncology
May 20, 2019

e23120 Background: Cancer patients experience symptoms which may precede diagnosis, occur during therapy, and persist into survivorship. Symptom assessments and patient reported outcomes have been shown to improve quality of life and extend survival in cancer patients. The Veterans Administration Symptom Assessment Scale (VSAS) is a clinical tool to document cancer-related symptoms. Here, we report VSAS adoption in five Veterans Health Administration (VHA) hematology-oncology sites during a five-year period. Methods: Data was collected from the Corporate Data Warehouse (CDW): VSAS data, date of birth, gender, race, ethnicity, vital status, year of cancer diagnosis, ICD-O-3, VHA facility, and clinic stop codes. Descriptive analyses of patient demographics, disease characteristics, and VSAS utilization was performed. VSAS is comprised of 13 symptoms, rated on a 0 to 10 scale. A VSAS visit was defined as the date the VSAS was administered to a patient. Results: From January 2013 through June 2018, there were 41,917 instances of VSAS administered to 9,409 unique patients at five VHA facilities: 8,512 (90.5%) were male; 5,241 (56%) were non-Hispanic White, 3,743 (40%) were Black, and 297 (3%) were other racial categories or not available. The median age at the first VSAS visit was 67 years. In patients whose oncologic diagnosis was recorded by a cancer registrar (4,536), the most common diagnoses were prostate cancer, lung cancer (all histologies), colon cancer, and multiple myeloma. The number of VSAS administrations increased annually, from 866 in 2013 to 12,775 in 2017, which may be attributed to increased adoption of VSAS across and within VHA facilities. Individual patients completed the VSAS 1-57 times (median 2). At the five VHA facilities utilizing VSAS in 2017, VSAS was administered at 56% of hematology-oncology clinic visits. Conclusions: VSAS is a tool to measure and document patient symptom burden, and has been successfully adopted in the last five years at select VHA facilities. Expanded use of VSAS throughout the VHA is an important step in improving the quality of life and extending survival of veterans with cancer and blood disorders.

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2019

Volume

37

Issue

15_suppl

Start / End Page

e23120 / e23120

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Friedman, D. R., Patil, V., Rasmussen, K. M., Sauer, B. C., Kelley, M. J., & Halwani, A. S. (2019). Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience. In Journal of Clinical Oncology (Vol. 37, pp. e23120–e23120). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2019.37.15_suppl.e23120
Friedman, Daphne Ruth, Vikas Patil, Kelli Marie Rasmussen, Brian C. Sauer, Michael J. Kelley, and Ahmad Sami Halwani. “Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience.” In Journal of Clinical Oncology, 37:e23120–e23120. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.e23120.
Friedman DR, Patil V, Rasmussen KM, Sauer BC, Kelley MJ, Halwani AS. Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019. p. e23120–e23120.
Friedman, Daphne Ruth, et al. “Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience.Journal of Clinical Oncology, vol. 37, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2019, pp. e23120–e23120. Crossref, doi:10.1200/jco.2019.37.15_suppl.e23120.
Friedman DR, Patil V, Rasmussen KM, Sauer BC, Kelley MJ, Halwani AS. Implementation of the VA Symptom Assessment Scale (VSAS): Five-year experience. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019. p. e23120–e23120.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2019

Volume

37

Issue

15_suppl

Start / End Page

e23120 / e23120

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences